Please sign in to follow a disease.
Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
Develops blood safety products, including pathogen reduction systems for blood components.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood treatment aims to make transfusions safer Results expected Dec 2026 (estimated)